Close

Novogen Limited's (NVGN) TRXE-009 Shown to be Highly Active Against Melanoma

December 16, 2014 8:11 AM EST Send to a Friend
Australian/US biotechnology company, Novogen Limited (NASDAQ: NVGN), today announces that it has confirmed that its lead candidate product, TRXE-009, originally ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login